Scott Sinner, MD
Infectious Disease · Batavia, OHNPI 1144296161
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Smith+Nephew at 28.2% of the total.
Across 52 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$244
- Misonix Inc$123
- Organogenesis Inc.$107
- Tactile Systems Technology Inc$90
- Viiv Healthcare Company$87
- Bsn Medical Inc$81
- plus $134 from 6 others
What the payments were for
- Food & beverage$85198%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 13 | $244 |
| Misonix Inc | 7 | $123 |
| Organogenesis Inc. | 7 | $107 |
| Tactile Systems Technology Inc | 5 | $90 |
| Viiv Healthcare Company | 5 | $87 |
| Bsn Medical Inc | 6 | $81 |
| Mimedx Group, Inc. | 2 | $32 |
| Cashflow Solutions, LLC | 2 | $28 |
| Integra Lifesciences Corporation | 1 | $21 |
| Kerecis Limited | 2 | $20 |
| AbbVie | 1 | $18 |
| 3M Company | 1 | $15 |
How this compares
$866 in reported general payments places this provider in the 65th percentile of 308 infectious disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErtapenemErtapenem Sodium | 16 | $7,637 |
| Daptomycin | 32 | $4,650 |
| Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod | 17 | $2,144 |
| Vancomycin Hcl | 24 | $1,306 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 59 | $1,249 |
| Cefazolin Sodium | 11 | $1,228 |
| Penicillin V Potassium | 53 | $754 |
| Doxycycline Hyclate | 19 | $421 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $400 |
| Gabapentin | 20 | $292 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $238 |
| Potassium Chloride | 15 | $232 |
| Sulfasalazine | 31 | $229 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 16 | $212 |
| Fluconazole | 21 | $195 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Batavia
- Steven BurdetteDayton$322K
- Nathaniel RatnasamyFindlay$255K
- Melissa JenkinsCleveland$127K
- Grace McComseyCleveland$123K
- Steven GordonCleveland$78K
- Nicholas CongerWright Patterson Afb$76K
- Alan TaegeCleveland$76K
- Carlos MalvestuttoColumbus$70K
- Thomas FileAkron$68K
- Nelson NicolasoraToledo$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.